Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|September 1, 2020
Development of Antisense Oligonucleotide Gapmers for the Treatment of Dyslipidemia and LipodystrophyTejal Aslesh, Toshifumi YokotaCells|February 15, 2022
Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular AtrophyTejal Aslesh, Toshifumi YokotaMethods in Molecular Biology (Clifton, N.J.)|September 1, 2020
Development of Antisense Oligonucleotide Gapmers for the Treatment of Huntington's DiseaseTejal Aslesh, Toshifumi YokotaBiomedicines|January 6, 2018
Skipping Multiple Exons to Treat DMD-Promises and ChallengesTejal Aslesh, Rika Maruyama, Toshifumi YokotaExpert Opinion on Biological Therapy|January 6, 2021
Restoration of dystrophin expression and correction of Duchenne muscular dystrophy by genome editingTejal Aslesh, Esra Erkut, Toshifumi YokotaMethods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Systemic Injection of Antisense Oligos into Spinal Muscular Atrophy (SMA) Mice and EvaluationTejal Aslesh, Rika Maruyama, Toshifumi YokotaMethods in Molecular Biology (Clifton, N.J.)|September 2, 2018
Systemic and ICV Injections of Antisense Oligos into SMA Mice and EvaluationTejal Aslesh, Rika Maruyama, Toshifumi YokotaInternational Journal of Molecular Sciences|January 21, 2023
Assessing the Role of Aquaporin 4 in Skeletal Muscle FunctionTejal Aslesh, Ammar Al-Aghbari, Toshifumi YokotaMethods in Molecular Biology (Clifton, N.J.)|September 2, 2018
Nusinersen in the Treatment of Spinal Muscular AtrophyKara Goodkey, Tejal Aslesh, Rika Maruyama, et al.JCI Insight|January 31, 2023
DG9-conjugated morpholino rescues phenotype in SMA mice by reaching the CNS via a subcutaneous administrationTejal Aslesh, Esra Erkut, Jun Ren, et al.Pageof 2